CoChat

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result

Open access
Westwood, Sarah, Baird, Alison L., Hye, Abdul, Ashton, Nicholas J., Nevado-Holgado, Alejo J., Anand, Sneha N., Liu, Benjamine, Newby, Danielle, Bazenet, Chantal, Kiddle, Steven J., Ward, Malcolm, Newton, Ben, Desai, Keyur, Tan Hehir, Cristina, Zanette, Michelle, Galimberti, Daniela, Parnetti, Lucilla, Lleó, Alberto, Baker, Susan, Narayan, Vaibhav A., van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Visser, Pieter Jelle, Lovestone, Simon · 2018 · Frontiers in Aging Neuroscience
Cited by 36

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. Objective: To discover a plasma proteomic signature associated with CSF and PET measures of AD pathology. Methods: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) based proteomics were performed in plasma from participants with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and AD, recruited to the Amsterdam Dementia Cohort, stratified by CSF Tau/Aβ42 (n=50). Technical replication and independent validation were performed by immunoassay in plasma from SCD, MCI and AD participants recruited to the Amsterdam Dementia Cohort with CSF measures (n=100), MCI participants enrolled in the GE067-005 study with [18F]-Flutemetamol PET amyloid measures (n=173), and AD, MCI and cognitively healthy participants from the EMIF 500 study with CSF Aβ42 measurements (n=494). Results: 25 discovery proteins were nominally associated with CSF Tau/Aβ42 (P < 0.05) with associations of ficolin-2 (FCN2), apolipoprotein C-IV and fibrinogen β chain confirmed by immunoassay (P < 0.05). In the GE067-005 cohort, FCN2 was nominally associated with PET amyloid (P < 0.05) replicating the association with CSF Tau/Aβ42. There were nominally significant associations of complement component 3 with PET amyloid, and apolipoprotein(a), apolipoprotein A-I, ceruloplasmin, and PPY with MCI conversion to AD (all P < 0.05). In the EMIF 500 cohort FCN2 was trending towards a significant relationship with CSF Aβ42 (P ≈ 0.05), while both A1AT and clusterin were nominally significantly associated with CSF Aβ42 (both P < 0.05). Conclusion: Associations of plasma proteins with multiple measures of AD pathology and progression are demonstrated. To our knowledge this is the first study to report an association of FCN2 with AD pathology. Further testing of the proteins in larger independent cohorts will be important.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2018.00409

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 36

Metadata

Authors
Westwood, S., Baird, A. L., Hye, A., Ashton, N. J., Nevado-Holgado, A. J., Anand, S. N., Liu, B., Newby, D., Bazenet, C., Kiddle, S. J., Ward, M., Newton, B., Desai, K., Tan Hehir, C., Zanette, M., Galimberti, D., Parnetti, L., Lleó, A., Baker, S., Narayan, V. A., van der Flier, W. M., Scheltens, P., Teunissen, C. E., Visser, P. J., & Lovestone, S.
Venue
Frontiers in Aging Neuroscience
Published
2018-12-11
Volume
10
Pages
409-409
ISSN
1663-4365 (ISSN-L)
OpenAlex
W2905383986
Cited by
36
References
19
FWCI
3.47
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result. https://app.cochat.ai/papers/10.3389/fnagi.2018.00409
The paper
Westwood, S., Baird, A. L., Hye, A., Ashton, N. J., Nevado-Holgado, A. J., Anand, S. N., Liu, B., Newby, D., Bazenet, C., Kiddle, S. J., Ward, M., Newton, B., Desai, K., Tan Hehir, C., Zanette, M., Galimberti, D., Parnetti, L., Lleó, A., Baker, S., . . . Lovestone, S. (2018). Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2018.00409

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.